Takeda Pharmaceutical Company Limited Cash Flows From Used In Operating Activities
Takeda Pharmaceutical Company Limited (TAK) reported Cash Flows From Used In Operating Activities of JPY 1.06 trillion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2025-06-25
| Period end | Cash Flows From Used In Operating Activities 12 month |
|---|---|
| 2025-03-31 | 1.06T JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 716.34B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 977.16B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 1.12T JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.01T JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 669.75B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 328.48B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 377.85B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 261.36B JPY 20-F · filed 2019-06-27 |